UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study

Annals of the rheumatic diseases, 2002-05, Vol.61 (5), p.398-404

2002

Volltextzugriff (PDF)

Thrombocytopaenia in lupus as a marker of adverse outcome : seeking Ariadne's thread

Rheumatology (Oxford, England), 2006-10, Vol.45 (10), p.1261-1265

2006

Volltextzugriff (PDF)

Prevalence of Sjögren’s syndrome in a closed rural community

Annals of the rheumatic diseases, 1997-09, Vol.56 (9), p.521-525

1997

Volltextzugriff (PDF)

Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women

Journal of bone and mineral research, 2004-04, Vol.19 (4), p.546-551

2004

Volltextzugriff (PDF)

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB11104 allele

Annals of the rheumatic diseases, 2000-05, Vol.59 (5), p.359-367

2000

Volltextzugriff (PDF)

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.2011-2018

2000

Volltextzugriff (PDF)

Evaluating Surrogate Markers of Clinical Outcome When Measured with Error

Biometrics, 1998-12, Vol.54 (4), p.1445-1462

1998

Volltextzugriff (PDF)

Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome

Arthritis and rheumatism, 1999-08, Vol.42 (8), p.1765-1772

1999

Volltextzugriff (PDF)

Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study

Rheumatology (Oxford, England), 1998-07, Vol.37 (7), p.740-745

1998

Volltextzugriff (PDF)

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment

Anticancer research, 1999-07, Vol.19 (4C), p.3543

1999

Volltextzugriff (PDF)

Dental and periodontal status of Sjögren's syndrome

Journal of clinical periodontology, 2000-04, Vol.27 (4), p.231-235

2000

Volltextzugriff (PDF)

ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension

The American heart journal, 2000-11, Vol.140 (5), p.760-765

2000

Volltextzugriff (PDF)

Pregnancy outcome and anti-RO/SSA in autoimmune diseases : A retrospective cohort study

British journal of rheumatology, 1998-07, Vol.37 (7), p.740-745

1998

Volltextzugriff (PDF)

A Method for Evaluating Surrogate Markers When Measured with Error Using the Cox Model

Drug information journal, 1994, Vol.28 (3), p.667-690

1994

Volltextzugriff (PDF)

ESMO-Magnitude of Clinical Benefit Scale version 1.1

Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366

2017

Volltextzugriff (PDF)

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Annals of oncology, 2015-08, Vol.26 (8), p.1547-1573

2015

Volltextzugriff (PDF)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Volltextzugriff (PDF)

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

Annals of oncology, 2019-12, Vol.30 (12), p.1902-1913

2019

Volltextzugriff (PDF)

Gender medicine and oncology: report and consensus of an ESMO workshop

Annals of oncology, 2019-12, Vol.30 (12), p.1914-1924

2019

Volltextzugriff (PDF)

Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

Annals of oncology, 2022-05, Vol.33 (5), p.511-521

2022

Volltextzugriff (PDF)

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis

Annals of oncology, 2024-10, Vol.35 (10), p.860-872

2024

Volltextzugriff (PDF)

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

Annals of oncology, 2023-12, Vol.34 (12), p.1097-1112

2023

Volltextzugriff (PDF)

Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis

European journal of cancer (1990), 2021-01, Vol.142, p.63-82

2021

Volltextzugriff (PDF)

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Annals of oncology, 2023-09, Vol.34 (9), p.734-771

2023

Volltextzugriff (PDF)

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Annals of oncology, 2017-11, Vol.28 (11), p.2901-2905

2017

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(117)
Bücher
(1)

Sprache

Englisch
(117)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(66)
Humans
(62)
Oncology
(48)
Female
(47)
Biological And Medical Sciences
(38)
Medical Sciences
(37)
Middle Aged
(36)
Adult
(33)
Male
(30)
Aged
(29)
Tumors
(15)
Chemotherapy
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Breast Cancer
(13)
Breast Neoplasms - Drug Therapy
(13)
Treatment Outcome
(13)
Aged, 80 And Over
(12)
Antineoplastic Agents
(11)
Gynecology. Andrology. Obstetrics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study

Thrombocytopaenia in lupus as a marker of adverse outcome : seeking Ariadne's thread

Prevalence of Sjögren’s syndrome in a closed rural community

Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB11104 allele

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury

Evaluating Surrogate Markers of Clinical Outcome When Measured with Error

Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome

Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment

Dental and periodontal status of Sjögren's syndrome

ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension

Pregnancy outcome and anti-RO/SSA in autoimmune diseases : A retrospective cohort study

A Method for Evaluating Surrogate Markers When Measured with Error Using the Cox Model

ESMO-Magnitude of Clinical Benefit Scale version 1.1

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

Gender medicine and oncology: report and consensus of an ESMO workshop

Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Suchergebnisse filtern